Chordia Therapeutics (190A.TSE) Q2 2026 Earnings

14AprConfirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-6.28
-5.62
-4.96
-4.3

Details

Expected EPS
N/A
Actual EPS
-4.7920488499800005
Surprise EPS
-4.79
Surprise Percent
+∞%

Description

Chordia Therapeutics (190A.TSE) has reported earnings of -4.7920488499800005 per share for Q2 2026.

0 Comments

Share your thoughts